Absorption |
Blood-Brain Barrier | BBB- | 0.9046 |
Human Intestinal Absorption | HIA- | 0.6944 |
Caco-2 Permeability | Caco2- | 0.6007 |
P-glycoprotein Substrate | Non-substrate | 0.5579 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7870 |
Non-inhibitor | 0.9754 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9429 |
Distribution |
Subcellular localization | Mitochondria | 0.3883 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8063 |
CYP450 2D6 Substrate | Non-substrate | 0.8136 |
CYP450 3A4 Substrate | Substrate | 0.5131 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.5958 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.7165 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8719 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.6959 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.7930 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6520 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9777 |
Non-inhibitor | 0.6787 |
AMES Toxicity | Non AMES toxic | 0.6269 |
Carcinogens | Carcinogens | 0.6069 |
Fish Toxicity | High FHMT | 0.9992 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.8703 |
Honey Bee Toxicity | Low HBT | 0.5941 |
Biodegradation | Not ready biodegradable | 0.9922 |
Acute Oral Toxicity | III | 0.5885 |
Carcinogenicity (Three-class) | Non-required | 0.5715 |